Average Co-Inventor Count = 3.00
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Nivalis Therapeutics, Inc. (8 from 19 patents)
2. N30 Pharmaceuticals, Inc. (2 from 17 patents)
10 patents:
1. 9856219 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
2. 9433618 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
3. 9364481 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
4. 9315462 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
5. 9249132 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
6. 9221810 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
7. 9139528 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
8. 9012646 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors
9. 8921562 - Substituted quinoline compounds as S-nitrosoglutathione reductase inhibitors
10. 8785643 - Substituted bicyclic aromatic compounds as S-nitrosoglutathione reductase inhibitors